HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and FGFR1 rearrangement.

AuthorsYiru Yan, Shiqiang Qu, Jinqin Liu, Chengwen Li, Xiao Yan, Zefeng Xu, Tiejun Qin, Yujiao Jia, Lijuan Pan, Qingyan Gao, Meng Jiao, Bing Li, Robert Peter Gale, Zhijian Xiao
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 64 Issue 9 Pg. 1605-1610 (09 2023) ISSN: 1029-2403 [Electronic] United States
PMID37354441 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • olverembatinib
  • Benzamides
  • Receptor, Fibroblast Growth Factor, Type 1
  • FGFR1 protein, human
Topics
  • Humans
  • Myeloproliferative Disorders (diagnosis, drug therapy, genetics)
  • Benzamides
  • Eosinophilia (genetics)
  • Lymphoma (complications)
  • Receptor, Fibroblast Growth Factor, Type 1 (genetics)
  • Gene Rearrangement
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: